✦ LIBER ✦

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

✍ Scribed by Joseph P Connor, Mihaela C Cristea, Nancy L Lewis, Lionel D Lewis…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

287 A phase Ib study of pertuzumab (P),

✍ J.W. Valle; C. Montagut; L.C. Pronk; E.T. Jones; M. Tosca; J. Beech; B. Taylor; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase I study of an outpatient regimen

✍ M. Huberman; H. Bering; B. Fallon; J. Tessitore; H. Sonnenborn; S. Paul; J. Zeff 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

1207 Results of study PX-171–007 a phase

✍ M. Gordon; J. Infante; K.P. Papadopoulos; P. Lee; E. Sausville; D. Mendelson; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A phase 1 study of the BCL2-targeted deo

✍ Tolcher, Anthony W.; Rodrigueza, Wendi V.; Rasco, Drew W.; Patnaik, Amita; Papad 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 692 KB

First-in-human phase 1/2a trial of CRLX1

✍ Glen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bass 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 823 KB

A phase 1 study evaluating the combinati

✍ Hudis, Clifford; Swanton, Charles; Janjigian, Yelena Y; Lee, Ray; Sutherland, St 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 622 KB